Professor Graeme Stewart

AM
Clinical Professor
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

Telephone +61 2 9845 6791
Fax +61 2 9891 3889

Map

Selected grants

2013

  • How do the Vitamin D Receptor activation genes CYP27B1 and CYP24A1 alter susceptibility to autoimmune diseases?; Booth D, Batten M, Stewart G, Liddle C; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Clinical implications of IL7R genotype: from disease risk to disease management; Stewart G, Booth D, Gottlieb D, McKay F, Vucic S, Rajasuriar R; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • The biologic and clinical implications of IL7Ra genotype in multiple sclerosis; Stewart G, Booth D, McKay F; Multiple Sclerosis Research Australia/Investigator Project Grants.

2011

  • The BD Influx High Speed Cell Sorter; Cunningham A, George J, Rizos H, Clarke C, Reddel R, Kefford R, North K, Stewart G, Jones C, Tam P, Alexander S, Gottlieb D, Bradstock K, Bryan T, Booth D, Bendall L, Brilot-Turville F, Hebbard L, Cooper S, Wang Y, Wang X; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Genetic Control of T cell Regulation in MS; Booth D, Stewart G, Vucic S, Heard R; Multiple Sclerosis Research Australia/Investigator Project Grants.
  • The effect of IL28B haplotype on hepatitis C virus infection and treatment response; Booth D, Ahlenstiel G, Stewart G, George J; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Functional Genomics to Predict and Enhance Response to Interferon; George J, Suppiah V, Kingston D, Bahlo M, Yang J, McKay F, Booth D, Stewart G, Bahlo M; Australian Research Council (ARC)/Linkage Projects (LP).
  • The role of PHF11 in CD4+T-cell lineage differenctiation and activation; Jones G, Stewart G; Westmead Charitable Trust/Bridging Grant.

2006

  • Host factors affecting of Hepatitis C-associated liver disease; Thomas D, George J, Stewart G, Booth D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Functional and Genetic Analysis of PHF11, a new gene associated with human atopic dermatitis and asthma; Jones G, Stewart G, Rolph M, Duffy D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Molecular response to interferon beta treatment in multiple sclerosis; Arthur J, Stewart G, Heard R, Booth D, Sedger L, Booth D, Stewart G, Heard R; Australian Research Council (ARC)/Linkage Projects (LP).

2005

  • Genes associated with multiple sclerosis; Stewart G, Booth D, Heard R, Compston A; National Health and Medical Research Council (NHMRC)/Project Grants.

2001

  • Detection of susceptibility genes for multiple sclerosis; Stewart G, Bennetts B, Heard R, Compston, A; National Health and Medical Research Council (NHMRC)/Project Grants.

2000

  • Transgenomic WAVE 2100 denaturing HPLC system for DNA variant analysis; Farrell G, Clarke C, Cunningham A, deFazio A, Kirk J, Leary J, Liddle C, Manolios N, Mitchell P, Stewart G, Mann G; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Genetic and biochemical control of the interleukin-2 mediated chemokine receptor response in HIV-disease; Stewart G, Williamson P; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity, 15(2), 88-94. [More Information]
  • O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity, 20(6), 598-605. [More Information]
  • Parnell, G., Gatt, P., McKay, F., Schibeci, S., Krupa, M., Powell, J., Visscher, P., Montgomery, G., Lechner-Scott, J., Broadley, S., Liddle, C., Vucic, S., Stewart, G., Booth, D., et al (2014). Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season. Multiple Sclerosis Journal, 20(6), 675-685. [More Information]
  • Parnell, G., Gatt, P., Krupa, M., Dorothee, N., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Vucic, S., Stewart, G., Booth, D., et al (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology, 151(1), 16-24. [More Information]
  • Shahijanian, F., Parnell, G., McKay, F., Gatt, P., Shojaei, M., O'Connor, K., Schibeci, S., Brilot-Turville, F., Liddle, C., Batten, M., Stewart, G., Booth, D. (2014). The CYP27B1 variant associated with increased risk of autoimmune disease is underexpressed in tolerising dendritic cells. Human Molecular Genetics, 23(6), 1425-1434. [More Information]
  • Mechelli, R., Umeton, R., Policano, C., Annibali, V., Coarelli, G., Ricigliano, V., Vittori, D., Fornasiero, A., Buscarinu, M., Booth, D., et al (2013). A "Candidate-Interactome" Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis. PLoS One, 8(5), 1-9. [More Information]
  • Beecham, A., Patsopoulos, N., Xifara, D., Davis, M., Kempinnen, A., Cotsapas, C., Shah, T., Spencer, C., Booth, D., Goris, A., Vucic, S., Stewart, G., et al (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353-1362. [More Information]
  • Fischer, J., Bohm, S., Muller, T., Witt, H., Sarrazin, C., Susser, S., Migaud, P., Schott, E., Stewart, G., Brodzinski, A., George, J., et al (2013). Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection. PLoS One, 8(10), 1-11. [More Information]
  • Suppiah, V., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Stewart, G., George, J., Booth, D., Ahlenstiel, G., et al (2013). CCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes and Immunity, 14(5), 286-290. [More Information]
  • Lee, S., Harold, D., Nyholt, D., Goddard, M., Zondervan, K., Williams, J., Montgomery, G., Wray, N., Visscher, P., Scott, R., Booth, D., Stewart, G., Heard, R., et al (2013). Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Human Molecular Genetics, 22(4), 832-841. [More Information]
  • Patsopoulos, N., Barcellos, L., Hintzen, R., Schaefer, C., van Duijn, C., Noble, J., Raj, T., Booth, D., Stewart, G., Heard, R., et al (2013). Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS One, 9(11), 1-10. [More Information]
  • Lin, R., Charlesworth, J., Stankovich, J., Perreau, V., Brown, M., Taylor, B., Baxter, A., Kermode, A., Bahlo, M., Booth, D., Stewart, G., Barnett, M., Heard, R., et al (2013). Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis. PLoS One, 8(3), 1-8. [More Information]
  • McKay, F., Hoe, E., Parnell, G., Gatt, P., Schibeci, S., Stewart, G., Booth, D. (2013). IL7Ralpha Expression and Upregulation by IFNbeta in Dendritic Cell Subsets Is Haplotype-Dependent. PLoS One, 8(10), 1-10. [More Information]
  • Lill, C., Schjeide, B., Graetz, C., Ban, M., Alcina, A., Ortiz, M., Perez, J., Damotte, V., Booth, D., de Lapuente, A., Stewart, G., et al (2013). MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain, 136(6), 1778-1782. [More Information]
  • Baranzini, S., Khankhanian, P., Patsopoulos, N., Li, M., Stankovich, J., Cotsapas, C., Bach Søndergaard, H., Ban, M., Booth, D., Stewart, G., et al (2013). Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls. American Journal of Human Genetics, 92, 854-865. [More Information]
  • Mero, I., Gustavsen, M., Sæther, H., Fla ̊ m, S., Berg-Hansen, P., Søndergaard, H., Jensen, P., Berge, T., Bjølgerud, A., et al, et al (2013). Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles. PLoS One, 8(3), e58352-e58352. [More Information]
  • Cortes, A., Field, J., Glazov, E., Hadler, J., Stankovich, J., Brown, M., Baxter, A., Kermode, A., Taylor, B., Booth, D., Stewart, G., Vucic, S., et al (2013). Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. Human Molecular Genetics, 22(11), 2283-2292. [More Information]
  • Martinelli-Boneschi, F., Esposito, F., Brambilla, P., Lindstrom, E., Lavorgna, G., Stankovich, J., Rodegher, M., Capra, R., Ghezzi, A., Coniglio, G., Booth, D., Stewart, G., et al (2012). A genome-wide association study in progressive multiple sclerosis. Multiple Sclerosis Journal, 18(10), 1384-1394. [More Information]
  • Fischer, J., Bohm, S., Scholz, M., Muller, T., Witt, H., George, J., Sarrazin, C., Susser, S., Schott, E., Suppiah, V., Booth, D., Stewart, G., et al (2012). Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology, 55(6), 1700-1710. [More Information]
  • Patin, E., Kutalik, Z., Guergnon, J., Bibert, S., Nalpas, B., Jouanguy, E., Munteanu, M., Bousquet, L., Argiro, L., Halfon, P., Suppiah, V., Stewart, G., Booth, D., George, J., et al (2012). Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection. Gastroenterology, 143(5), 1244-1252. [More Information]
  • Rajasuriar, R., Booth, D., Gouillou, M., Spelman, T., James, I., Solomon, A., Chua, K., Stewart, G., Deeks, S., Bangsberg, D., et al (2012). The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART. Genes and Immunity, 13(1), 83-93. [More Information]
  • Suan, D., Booth, D., Kennedy, I., Downie, J., Earls, P., Gottlieb, D., Stewart, G., Ling, M. (2012). Vitreal deposits in Val71Ala transthyretin amyloidosis. Internal Medicine Journal, 42(1), 106-108. [More Information]
  • Sawcer, S., Hallenthal, G., Pirinen, M., Spencer, C., Patsopoulos, N., Moutsianas, L., Dilthey, A., Su, Z., et al, Booth, D., Heard, R., Stewart, G. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476(7359), 214-219. [More Information]
  • Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3(8), 57-1-57-13. [More Information]
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine, 8(9), e1001092-1-e1001092-8. [More Information]
  • Suan, D., O'Connor, K., Booth, D., Liddle, C., Stewart, G. (2011). Voriconazole toxicity related to polymorphisms in CYP2C19. Internal Medicine Journal, 41(4), 364-365. [More Information]
  • Field, J., Browning, S., Johnson, L., Danoy, P., Varney, M., Tait, B., Gandhi, K., Charlesworth, J., Heard, R., The Australia and New Zealand Multiple Sclerosis Genetics Consortium, (., Stewart, G., Booth, D., et al (2010). A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis. PLoS One, 5(10, Article number e13454), e13454 - 1-e13454 - 7. [More Information]
  • Rahman, N., Stewart, G., Jones, G. (2010). A role for the atopy-associated gene PHF11 in T-cell activation and viability. Immunology and Cell Biology, 88(8), 817-824. [More Information]
  • Riveros, C., Mellor, D., Gandhi, K., McKay, F., Cox, M., Berretta, R., Vaezpour, S., Inostroza-Ponta, M., Broadley, S., Heard, R., Vucic, S., Stewart, G., Booth, D., et al (2010). A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis. PLoS One, 5(12), e14176-1-e14176-28. [More Information]
  • Jones, G., Stewart, G. (2010). Association of PHF11 polymorphisms with asthma and allergy. Thorax, 65(7), 659-660. [More Information]
  • Rajasuriar, R., Booth, D., Solomon, A., Chua, K., Spelman, T., Gouillou, M., Schlub, T., Davenport, M., Crowe, S., Elliot, J., Stewart, G., et al (2010). Biological Determinants of Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor alpha and Microbial Translocation. The Journal of Infectious Diseases, 202(8), 1254-1264. [More Information]
  • Sedger, L., Katewa, A., Petterson, A., Osvath, S., Farrell, G., Stewart, G., Bendall, L., Alexander, S. (2010). Extreme lymphoproliferative disease and fatal autoimmune thrombocytopenia in FasL- and TRAIL-double deficient mice. Blood, 115(16), 3258-3268. [More Information]
  • Hoe, E., McKay, F., Schibeci, S., Gandhi, K., Heard, R., Stewart, G., Booth, D. (2010). Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. Journal of Immunology, 184(5), 2512-2517. [More Information]
  • Esposito, F., Patsopolous, N., Cepok, S., Kockum, J., Leppa, V., Booth, D., Heard, R., Stewart, G., Cox, M., Scott, R., et al (2010). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes and Immunity, 11(5), 397-405. [More Information]
  • Hoe, E., McKay, F., Schibeci, S., Heard, R., Stewart, G., Booth, D. (2010). Interleukin 7 Receptor Alpha Chain (IL-7Ralpha) Haplotypes Vary in Their Influence on Multiple Sclerosis Susceptibility and Response to Interferon Beta. Journal of Interferon and Cytokine Research, 30(5), 291-298. [More Information]
  • Booth, D., Heard, R., Stewart, G., Cox, M., Scott, R., Lechner-Scott, J., Goris, A., Dobosi, R., Dubois, B., Saarela, J., et al (2010). Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nature Genetics, 42(6), 469-470. [More Information]
  • Cox, M., Cairns, M., Gandhi, K., Carroll, A., Moscovis, S., Stewart, G., Broadley, S., Scott, R., Booth, D., Lechner-Scott, J., et al (2010). MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood. PLoS One, 5(8), e12132 - 1-e12132 - 7. [More Information]
  • Gandhi, K., McKay, F., Diefenbach, E., Crossett, B., Schibeci, S., Heard, R., Stewart, G., Booth, D., Arthur, J. (2010). Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis. PLoS One, 5(5), e10484 - 1-e10484 - 9. [More Information]
  • Gandhi, K., McKay, F., Cox, M., Riveros, C., Armstrong, N., Heard, R., Vucic, S., Williams, D., Stankovich, J., Brown, M., Stewart, G., Booth, D., et al (2010). The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Human Molecular Genetics, 19(11), 2134-2143. [More Information]
  • Bahlo, M., Booth, D., Broadley, S., Brown, M., Foote, S., Griffiths, L., Kilpatrick, T., Lechner-Scott, J., Moscato, P., Perreau, V., Stewart, G., Wiley, J., et al (2009). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature Genetics, 41(7), 824-830.
  • Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Stewart, G., Booth, D., George, J., et al (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics, 41(10), 1100-1104. [More Information]
  • Stewart, G., Dwyer, J. (2009). Implementation of the Garling recommendations can offer real hope for rescuing the New South Wales public hospital system. Medical Journal of Australia, 190(2), 80-82. [More Information]
  • Stewart, G. (2009). Multiple sclerosis and vitamin D: don't (yet) blame it on the sunshine. Brain: a journal of neurology, 132(5), 1126-1127. [More Information]
  • Ban, M., Goris, A., Lorentzen, A., Baker, A., Mihalova, T., Ingram, G., Booth, D., Heard, R., Stewart, G., Bogaert, E., et al (2009). Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. European Journal of Human Genetics, 17, 1309-1313. [More Information]
  • De Jager, P., Baecher-Allan, C., Maier, L., Arthur, A., Ottoboni, L., Barcellos, L., McCauley, J., Sawcer, S., Goris, A., Saarela, J., Booth, D., Stewart, G., et al (2009). The role of the CD58 locus in multiple sclerosis. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 106(13), 5264-5269. [More Information]
  • Gandhi, K., McKay, F., Schibeci, S., Arthur, J., Heard, R., Stewart, G., Booth, D. (2008). BAFF is a Biological Response Marker to IFN-beta Treatment in Multiple Sclerosis. Journal of Interferon and Cytokine Research, 28(9), 529-540. [More Information]
  • Clarke, E., Rahman, N., Page, N., Rolph, M., Stewart, G., Jones, G. (2008). Functional characterization of the atopy-associated gene PHF11. Journal of Allergy and Clinical Immunology, 121(5), 1148 +sup e1-1154 +sup e3. [More Information]
  • Arthur, A., Armati, P., Bye, C., The Southern MS Genetics Consortium, N., Heard, R., Stewart, G., Pollard, J., Booth, D. (2008). Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Medical Genetics, 9(17), 1-12. [More Information]
  • Burfoot, R., Jensen, C., Field, J., Stankovich, J., Varney, M., Johnson, L., Butzkueven, H., Booth, D., Bahlo, M., Tait, B., Heard, R., Stewart, G., et al (2008). SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens: immune response genetics, 71(1), 42-50. [More Information]
  • Horton, P., Hawthorne, W., Walters, S., Patel, T., Stewart, G., Allen, R., Chapman, J. (2008). Tolerance Induction in a Large-Animal Model Using Total Lymphoid Irradiation and Intrathymic Bone Marrow. Transplantation, 86(12), 1830-1836. [More Information]
  • Hensiek, A., Seaman, S., Barcellos, L., Oturai, A., Eraksoi, M., Cocco, E., Vecsei, L., Stewart, G., Dubois, B., Bellman-Strobl, J., Booth, D., et al (2007). Familial effects on the clinical course of multiple sclerosis. Neurology, 68(5), 376-383. [More Information]
  • McKay, F., Swain, L., Schibeci, S., Rubio, J., Kilpatrick, T., Heard, R., Stewart, G., Booth, D. (2007). Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes and Immunity, 9((accepted 6 September, 2007)), 1-6. [More Information]
  • Gabutero, E., Moore, C., Mallal, S., Stewart, G., Williamson, P. (2007). Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS. AIDS, 21(1), 65-69. [More Information]
  • Bugeja, M., Booth, D., Bennetts, B., Heard, R., Rubio, J., Stewart, G. (2006). An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Medical Genetics, 7, 64-64. [More Information]
  • Bugeja, M., Booth, D., Bennetts, B., Heard, R., Stewart, G. (2006). An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians. Multiple Sclerosis: clinical and laboratory research, 12(6), 710-722. [More Information]
  • McKay, F., Schibeci, S., Heard, R., Stewart, G., Booth, D. (2006). Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australasian cohort. Journal of Immunological Methods, 310(1-2), 20-29. [More Information]
  • Page, N., Jones, G., Stewart, G. (2006). Genetic Association Studies between the T Cell Immunoglobulin Mucin (TIM) Gene Locus and Childhood Atopic Dermatitis. International Archives Of Allergy And Immunology, 141(4), 331-336. [More Information]
  • Jones, G., Wu, S., Jang, N., Fulcher, D., Hogan, P., Stewart, G. (2006). Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. British Journal of Dermatology, 154(3), 467-471. [More Information]
  • Stewart, G., Dwyer, J., Goulston, K. (2006). The Greater Metropolitan Clinical Taskforce: an Australian model for clinician governance. Medical Journal of Australia, 184(12), 597-8. [More Information]
  • Sawcer, S., Ban, M., Maranian, M., Yeo, T., Compston, A., Kirby, A., Daly, M., De Jager, P., Walsh, E., Heard, R., Stewart, G., Booth, D., et al (2005). A high-density screen for linkage in multiple sclerosis. American Journal of Human Genetics. [More Information]
  • Bugeja, M., Booth, D., Bennetts, B., Heard, R., Burgner, D., Stewart, G. (2005). An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. European Journal of Human Genetics, 13(7), 815-822. [More Information]
  • Jang, N., Stewart, G., Jones, G. (2005). Polymorphisms within the PHF11 gene at chromosome 13q14 are associated with childhood atopic dermatitis. Genes and Immunity, 6(3), 262-264. [More Information]
  • Bugeja, M., Booth, D., Bennetts, B., Guerin, J., Kaldor, J., Stewart, G. (2004). Analysis Of The Ccl3-L1 Gene For Association With Hiv-1 Susceptibility And Disease Progression. AIDS, 18(7), 1069-1071.
  • Teutsch, S., Booth, D., Bennetts, B., Heard, R., Stewart, G. (2004). Association Of Common T Cell Activation Gene Polymorphisms With Multiple Sclerosis In Australian Patients. Journal of Neuroimmunology, 148(2), 218-30. [More Information]
  • Dao-Ung, L., Fuller, S., Sluyter, R., Skarratt, K., Thunberg, U., Tobin, G., Byth Wilson, K., Ban, M., Rosenquist, R., Stewart, G., Wiley, J. (2004). Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. British Journal of Haematology, 125(6), 815-817.
  • Djordjevic, J., Schibeci, S., Stewart, G., Williamson, P. (2004). Hiv Type 1 Nef Increases The Association Of T Cell Receptor (Tcr)-Signaling Molecules With T Cell Rafts And Promotes Activation-Induced Raft Fusion. AIDS Research and Human Retroviruses, 20(5), 547-555.
  • Jones, G., Stewart, G. (2004). Nuclear Import Of N-Terminal Fak By Activation Of The Fcepsilonri Receptor In Rbl-2H3 Cells. Biochemical and Biophysical Research Communications, 314(1), 39-45. [More Information]
  • Clegg, A., Williamson, P., Biti, R., Cooper, D., Emery, S., Carr, A., Stewart, G. (2003). Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals. Clinical Immunology, 106(1), 36-40.
  • Young, J., Stewart, G., Fulcher, D., Benson, E., Ffrench, R., Clarkson, J., Liang,, T., Tideman, R., Packham, D. (2001). In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by Interleukin-12 (IL-12). AIDS Research and Human Retroviruses, 17, 233-242.
  • Gala, S., Stewart, G., Williamson, P., Marreiros, A. (2001). Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood, 97, 227-234.
  • Huang, Q., Teutsch, S., Buhler, M., Bennetts, B., Heard, R., Manolios, N., Stewart, G. (2000). Evaluation of the Apo-1/Fas promoter Mva 1 polymorphism in multiple sclerosis. Multiple Sclerosis: clinical and laboratory research, 6(1), 14-18.
  • Wallman, L., Stewart, G., Chapman, J., O'Connell, P., Fulcher, D. (2000). Mycophenolate mofetil for treatment of refractory lupus nephritis: four pilot cases. Internal Medicine Journal, 30, 712-715.

Conferences

  • Tran, P., Hing, A., Hicks, M., Gao, L., Faddy, S., Kesteven, S., Stewart, G., Macdonald, P., Sharland, A. (2006). Expression of NKG2D ligands following brain-death. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Djordjevic, J., Schibeci, S., Stewart, G., Williamson, P. (2002). Effect of HIV-1 Nef on cell membrane organisation. Implications for T-cell signalling. 14th Annual Conference of the Australasian Society for HIV Medicine.
  • Djordjevic, J., Schibeci, S., Lee, K., Gala, S., Stewart, G., Williamson, P. (2002). Effect of HIV-1 Nef on plasma membrane organisation. Third College of Health Sciences Research Conference 2002.
  • Djordjevic, J., Schibeci, S., Stewart, G., Williamson, P. (2002). HIV-1 Nef affects clustering of T cell lipid rafts. Implications for T-cell signalling. ASI Annual Scientific Meeting 2002.
  • Lee, K., Schibeci, S., Djordjevic, J., Stewart, G., Williamson, P. (2002). Mutation of HIV-1 Nef proline-rich region inhibits T-cell migration. Third College of Health Sciences Research Conference 2002.

Working Paper Internal

  • Kerridge, I., Stewart, G., Raper, M., Celermajer, D., Willcock, S. (2004). "The Future of Medicine" - What is wrong with medicine today? and Where is the future of medicine?.

2014

  • O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity, 15(2), 88-94. [More Information]
  • O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity, 20(6), 598-605. [More Information]
  • Parnell, G., Gatt, P., McKay, F., Schibeci, S., Krupa, M., Powell, J., Visscher, P., Montgomery, G., Lechner-Scott, J., Broadley, S., Liddle, C., Vucic, S., Stewart, G., Booth, D., et al (2014). Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season. Multiple Sclerosis Journal, 20(6), 675-685. [More Information]
  • Parnell, G., Gatt, P., Krupa, M., Dorothee, N., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Vucic, S., Stewart, G., Booth, D., et al (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology, 151(1), 16-24. [More Information]
  • Shahijanian, F., Parnell, G., McKay, F., Gatt, P., Shojaei, M., O'Connor, K., Schibeci, S., Brilot-Turville, F., Liddle, C., Batten, M., Stewart, G., Booth, D. (2014). The CYP27B1 variant associated with increased risk of autoimmune disease is underexpressed in tolerising dendritic cells. Human Molecular Genetics, 23(6), 1425-1434. [More Information]

2013

  • Mechelli, R., Umeton, R., Policano, C., Annibali, V., Coarelli, G., Ricigliano, V., Vittori, D., Fornasiero, A., Buscarinu, M., Booth, D., et al (2013). A "Candidate-Interactome" Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis. PLoS One, 8(5), 1-9. [More Information]
  • Beecham, A., Patsopoulos, N., Xifara, D., Davis, M., Kempinnen, A., Cotsapas, C., Shah, T., Spencer, C., Booth, D., Goris, A., Vucic, S., Stewart, G., et al (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353-1362. [More Information]
  • Fischer, J., Bohm, S., Muller, T., Witt, H., Sarrazin, C., Susser, S., Migaud, P., Schott, E., Stewart, G., Brodzinski, A., George, J., et al (2013). Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection. PLoS One, 8(10), 1-11. [More Information]
  • Suppiah, V., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Stewart, G., George, J., Booth, D., Ahlenstiel, G., et al (2013). CCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes and Immunity, 14(5), 286-290. [More Information]
  • Lee, S., Harold, D., Nyholt, D., Goddard, M., Zondervan, K., Williams, J., Montgomery, G., Wray, N., Visscher, P., Scott, R., Booth, D., Stewart, G., Heard, R., et al (2013). Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Human Molecular Genetics, 22(4), 832-841. [More Information]
  • Patsopoulos, N., Barcellos, L., Hintzen, R., Schaefer, C., van Duijn, C., Noble, J., Raj, T., Booth, D., Stewart, G., Heard, R., et al (2013). Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS One, 9(11), 1-10. [More Information]
  • Lin, R., Charlesworth, J., Stankovich, J., Perreau, V., Brown, M., Taylor, B., Baxter, A., Kermode, A., Bahlo, M., Booth, D., Stewart, G., Barnett, M., Heard, R., et al (2013). Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis. PLoS One, 8(3), 1-8. [More Information]
  • McKay, F., Hoe, E., Parnell, G., Gatt, P., Schibeci, S., Stewart, G., Booth, D. (2013). IL7Ralpha Expression and Upregulation by IFNbeta in Dendritic Cell Subsets Is Haplotype-Dependent. PLoS One, 8(10), 1-10. [More Information]
  • Lill, C., Schjeide, B., Graetz, C., Ban, M., Alcina, A., Ortiz, M., Perez, J., Damotte, V., Booth, D., de Lapuente, A., Stewart, G., et al (2013). MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain, 136(6), 1778-1782. [More Information]
  • Baranzini, S., Khankhanian, P., Patsopoulos, N., Li, M., Stankovich, J., Cotsapas, C., Bach Søndergaard, H., Ban, M., Booth, D., Stewart, G., et al (2013). Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls. American Journal of Human Genetics, 92, 854-865. [More Information]
  • Mero, I., Gustavsen, M., Sæther, H., Fla ̊ m, S., Berg-Hansen, P., Søndergaard, H., Jensen, P., Berge, T., Bjølgerud, A., et al, et al (2013). Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles. PLoS One, 8(3), e58352-e58352. [More Information]
  • Cortes, A., Field, J., Glazov, E., Hadler, J., Stankovich, J., Brown, M., Baxter, A., Kermode, A., Taylor, B., Booth, D., Stewart, G., Vucic, S., et al (2013). Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. Human Molecular Genetics, 22(11), 2283-2292. [More Information]

2012

  • Martinelli-Boneschi, F., Esposito, F., Brambilla, P., Lindstrom, E., Lavorgna, G., Stankovich, J., Rodegher, M., Capra, R., Ghezzi, A., Coniglio, G., Booth, D., Stewart, G., et al (2012). A genome-wide association study in progressive multiple sclerosis. Multiple Sclerosis Journal, 18(10), 1384-1394. [More Information]
  • Fischer, J., Bohm, S., Scholz, M., Muller, T., Witt, H., George, J., Sarrazin, C., Susser, S., Schott, E., Suppiah, V., Booth, D., Stewart, G., et al (2012). Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology, 55(6), 1700-1710. [More Information]
  • Patin, E., Kutalik, Z., Guergnon, J., Bibert, S., Nalpas, B., Jouanguy, E., Munteanu, M., Bousquet, L., Argiro, L., Halfon, P., Suppiah, V., Stewart, G., Booth, D., George, J., et al (2012). Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection. Gastroenterology, 143(5), 1244-1252. [More Information]
  • Rajasuriar, R., Booth, D., Gouillou, M., Spelman, T., James, I., Solomon, A., Chua, K., Stewart, G., Deeks, S., Bangsberg, D., et al (2012). The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART. Genes and Immunity, 13(1), 83-93. [More Information]
  • Suan, D., Booth, D., Kennedy, I., Downie, J., Earls, P., Gottlieb, D., Stewart, G., Ling, M. (2012). Vitreal deposits in Val71Ala transthyretin amyloidosis. Internal Medicine Journal, 42(1), 106-108. [More Information]

2011

  • Sawcer, S., Hallenthal, G., Pirinen, M., Spencer, C., Patsopoulos, N., Moutsianas, L., Dilthey, A., Su, Z., et al, Booth, D., Heard, R., Stewart, G. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476(7359), 214-219. [More Information]
  • Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3(8), 57-1-57-13. [More Information]
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine, 8(9), e1001092-1-e1001092-8. [More Information]
  • Suan, D., O'Connor, K., Booth, D., Liddle, C., Stewart, G. (2011). Voriconazole toxicity related to polymorphisms in CYP2C19. Internal Medicine Journal, 41(4), 364-365. [More Information]

2010

  • Field, J., Browning, S., Johnson, L., Danoy, P., Varney, M., Tait, B., Gandhi, K., Charlesworth, J., Heard, R., The Australia and New Zealand Multiple Sclerosis Genetics Consortium, (., Stewart, G., Booth, D., et al (2010). A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis. PLoS One, 5(10, Article number e13454), e13454 - 1-e13454 - 7. [More Information]
  • Rahman, N., Stewart, G., Jones, G. (2010). A role for the atopy-associated gene PHF11 in T-cell activation and viability. Immunology and Cell Biology, 88(8), 817-824. [More Information]
  • Riveros, C., Mellor, D., Gandhi, K., McKay, F., Cox, M., Berretta, R., Vaezpour, S., Inostroza-Ponta, M., Broadley, S., Heard, R., Vucic, S., Stewart, G., Booth, D., et al (2010). A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis. PLoS One, 5(12), e14176-1-e14176-28. [More Information]
  • Jones, G., Stewart, G. (2010). Association of PHF11 polymorphisms with asthma and allergy. Thorax, 65(7), 659-660. [More Information]
  • Rajasuriar, R., Booth, D., Solomon, A., Chua, K., Spelman, T., Gouillou, M., Schlub, T., Davenport, M., Crowe, S., Elliot, J., Stewart, G., et al (2010). Biological Determinants of Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor alpha and Microbial Translocation. The Journal of Infectious Diseases, 202(8), 1254-1264. [More Information]
  • Sedger, L., Katewa, A., Petterson, A., Osvath, S., Farrell, G., Stewart, G., Bendall, L., Alexander, S. (2010). Extreme lymphoproliferative disease and fatal autoimmune thrombocytopenia in FasL- and TRAIL-double deficient mice. Blood, 115(16), 3258-3268. [More Information]
  • Hoe, E., McKay, F., Schibeci, S., Gandhi, K., Heard, R., Stewart, G., Booth, D. (2010). Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. Journal of Immunology, 184(5), 2512-2517. [More Information]
  • Esposito, F., Patsopolous, N., Cepok, S., Kockum, J., Leppa, V., Booth, D., Heard, R., Stewart, G., Cox, M., Scott, R., et al (2010). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes and Immunity, 11(5), 397-405. [More Information]
  • Hoe, E., McKay, F., Schibeci, S., Heard, R., Stewart, G., Booth, D. (2010). Interleukin 7 Receptor Alpha Chain (IL-7Ralpha) Haplotypes Vary in Their Influence on Multiple Sclerosis Susceptibility and Response to Interferon Beta. Journal of Interferon and Cytokine Research, 30(5), 291-298. [More Information]
  • Booth, D., Heard, R., Stewart, G., Cox, M., Scott, R., Lechner-Scott, J., Goris, A., Dobosi, R., Dubois, B., Saarela, J., et al (2010). Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nature Genetics, 42(6), 469-470. [More Information]
  • Cox, M., Cairns, M., Gandhi, K., Carroll, A., Moscovis, S., Stewart, G., Broadley, S., Scott, R., Booth, D., Lechner-Scott, J., et al (2010). MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood. PLoS One, 5(8), e12132 - 1-e12132 - 7. [More Information]
  • Gandhi, K., McKay, F., Diefenbach, E., Crossett, B., Schibeci, S., Heard, R., Stewart, G., Booth, D., Arthur, J. (2010). Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis. PLoS One, 5(5), e10484 - 1-e10484 - 9. [More Information]
  • Gandhi, K., McKay, F., Cox, M., Riveros, C., Armstrong, N., Heard, R., Vucic, S., Williams, D., Stankovich, J., Brown, M., Stewart, G., Booth, D., et al (2010). The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Human Molecular Genetics, 19(11), 2134-2143. [More Information]

2009

  • Bahlo, M., Booth, D., Broadley, S., Brown, M., Foote, S., Griffiths, L., Kilpatrick, T., Lechner-Scott, J., Moscato, P., Perreau, V., Stewart, G., Wiley, J., et al (2009). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature Genetics, 41(7), 824-830.
  • Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Stewart, G., Booth, D., George, J., et al (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics, 41(10), 1100-1104. [More Information]
  • Stewart, G., Dwyer, J. (2009). Implementation of the Garling recommendations can offer real hope for rescuing the New South Wales public hospital system. Medical Journal of Australia, 190(2), 80-82. [More Information]
  • Stewart, G. (2009). Multiple sclerosis and vitamin D: don't (yet) blame it on the sunshine. Brain: a journal of neurology, 132(5), 1126-1127. [More Information]
  • Ban, M., Goris, A., Lorentzen, A., Baker, A., Mihalova, T., Ingram, G., Booth, D., Heard, R., Stewart, G., Bogaert, E., et al (2009). Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. European Journal of Human Genetics, 17, 1309-1313. [More Information]
  • De Jager, P., Baecher-Allan, C., Maier, L., Arthur, A., Ottoboni, L., Barcellos, L., McCauley, J., Sawcer, S., Goris, A., Saarela, J., Booth, D., Stewart, G., et al (2009). The role of the CD58 locus in multiple sclerosis. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 106(13), 5264-5269. [More Information]

2008

  • Gandhi, K., McKay, F., Schibeci, S., Arthur, J., Heard, R., Stewart, G., Booth, D. (2008). BAFF is a Biological Response Marker to IFN-beta Treatment in Multiple Sclerosis. Journal of Interferon and Cytokine Research, 28(9), 529-540. [More Information]
  • Clarke, E., Rahman, N., Page, N., Rolph, M., Stewart, G., Jones, G. (2008). Functional characterization of the atopy-associated gene PHF11. Journal of Allergy and Clinical Immunology, 121(5), 1148 +sup e1-1154 +sup e3. [More Information]
  • Arthur, A., Armati, P., Bye, C., The Southern MS Genetics Consortium, N., Heard, R., Stewart, G., Pollard, J., Booth, D. (2008). Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Medical Genetics, 9(17), 1-12. [More Information]
  • Burfoot, R., Jensen, C., Field, J., Stankovich, J., Varney, M., Johnson, L., Butzkueven, H., Booth, D., Bahlo, M., Tait, B., Heard, R., Stewart, G., et al (2008). SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens: immune response genetics, 71(1), 42-50. [More Information]
  • Horton, P., Hawthorne, W., Walters, S., Patel, T., Stewart, G., Allen, R., Chapman, J. (2008). Tolerance Induction in a Large-Animal Model Using Total Lymphoid Irradiation and Intrathymic Bone Marrow. Transplantation, 86(12), 1830-1836. [More Information]

2007

  • Hensiek, A., Seaman, S., Barcellos, L., Oturai, A., Eraksoi, M., Cocco, E., Vecsei, L., Stewart, G., Dubois, B., Bellman-Strobl, J., Booth, D., et al (2007). Familial effects on the clinical course of multiple sclerosis. Neurology, 68(5), 376-383. [More Information]
  • McKay, F., Swain, L., Schibeci, S., Rubio, J., Kilpatrick, T., Heard, R., Stewart, G., Booth, D. (2007). Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes and Immunity, 9((accepted 6 September, 2007)), 1-6. [More Information]
  • Gabutero, E., Moore, C., Mallal, S., Stewart, G., Williamson, P. (2007). Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS. AIDS, 21(1), 65-69. [More Information]

2006

  • Bugeja, M., Booth, D., Bennetts, B., Heard, R., Rubio, J., Stewart, G. (2006). An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Medical Genetics, 7, 64-64. [More Information]
  • Bugeja, M., Booth, D., Bennetts, B., Heard, R., Stewart, G. (2006). An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians. Multiple Sclerosis: clinical and laboratory research, 12(6), 710-722. [More Information]
  • McKay, F., Schibeci, S., Heard, R., Stewart, G., Booth, D. (2006). Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australasian cohort. Journal of Immunological Methods, 310(1-2), 20-29. [More Information]
  • Tran, P., Hing, A., Hicks, M., Gao, L., Faddy, S., Kesteven, S., Stewart, G., Macdonald, P., Sharland, A. (2006). Expression of NKG2D ligands following brain-death. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Page, N., Jones, G., Stewart, G. (2006). Genetic Association Studies between the T Cell Immunoglobulin Mucin (TIM) Gene Locus and Childhood Atopic Dermatitis. International Archives Of Allergy And Immunology, 141(4), 331-336. [More Information]
  • Jones, G., Wu, S., Jang, N., Fulcher, D., Hogan, P., Stewart, G. (2006). Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. British Journal of Dermatology, 154(3), 467-471. [More Information]
  • Stewart, G., Dwyer, J., Goulston, K. (2006). The Greater Metropolitan Clinical Taskforce: an Australian model for clinician governance. Medical Journal of Australia, 184(12), 597-8. [More Information]

2005

  • Sawcer, S., Ban, M., Maranian, M., Yeo, T., Compston, A., Kirby, A., Daly, M., De Jager, P., Walsh, E., Heard, R., Stewart, G., Booth, D., et al (2005). A high-density screen for linkage in multiple sclerosis. American Journal of Human Genetics. [More Information]
  • Bugeja, M., Booth, D., Bennetts, B., Heard, R., Burgner, D., Stewart, G. (2005). An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. European Journal of Human Genetics, 13(7), 815-822. [More Information]
  • Jang, N., Stewart, G., Jones, G. (2005). Polymorphisms within the PHF11 gene at chromosome 13q14 are associated with childhood atopic dermatitis. Genes and Immunity, 6(3), 262-264. [More Information]

2004

  • Kerridge, I., Stewart, G., Raper, M., Celermajer, D., Willcock, S. (2004). "The Future of Medicine" - What is wrong with medicine today? and Where is the future of medicine?.
  • Bugeja, M., Booth, D., Bennetts, B., Guerin, J., Kaldor, J., Stewart, G. (2004). Analysis Of The Ccl3-L1 Gene For Association With Hiv-1 Susceptibility And Disease Progression. AIDS, 18(7), 1069-1071.
  • Teutsch, S., Booth, D., Bennetts, B., Heard, R., Stewart, G. (2004). Association Of Common T Cell Activation Gene Polymorphisms With Multiple Sclerosis In Australian Patients. Journal of Neuroimmunology, 148(2), 218-30. [More Information]
  • Dao-Ung, L., Fuller, S., Sluyter, R., Skarratt, K., Thunberg, U., Tobin, G., Byth Wilson, K., Ban, M., Rosenquist, R., Stewart, G., Wiley, J. (2004). Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia. British Journal of Haematology, 125(6), 815-817.
  • Djordjevic, J., Schibeci, S., Stewart, G., Williamson, P. (2004). Hiv Type 1 Nef Increases The Association Of T Cell Receptor (Tcr)-Signaling Molecules With T Cell Rafts And Promotes Activation-Induced Raft Fusion. AIDS Research and Human Retroviruses, 20(5), 547-555.
  • Jones, G., Stewart, G. (2004). Nuclear Import Of N-Terminal Fak By Activation Of The Fcepsilonri Receptor In Rbl-2H3 Cells. Biochemical and Biophysical Research Communications, 314(1), 39-45. [More Information]

2003

  • Clegg, A., Williamson, P., Biti, R., Cooper, D., Emery, S., Carr, A., Stewart, G. (2003). Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals. Clinical Immunology, 106(1), 36-40.

2002

  • Djordjevic, J., Schibeci, S., Stewart, G., Williamson, P. (2002). Effect of HIV-1 Nef on cell membrane organisation. Implications for T-cell signalling. 14th Annual Conference of the Australasian Society for HIV Medicine.
  • Djordjevic, J., Schibeci, S., Lee, K., Gala, S., Stewart, G., Williamson, P. (2002). Effect of HIV-1 Nef on plasma membrane organisation. Third College of Health Sciences Research Conference 2002.
  • Djordjevic, J., Schibeci, S., Stewart, G., Williamson, P. (2002). HIV-1 Nef affects clustering of T cell lipid rafts. Implications for T-cell signalling. ASI Annual Scientific Meeting 2002.
  • Lee, K., Schibeci, S., Djordjevic, J., Stewart, G., Williamson, P. (2002). Mutation of HIV-1 Nef proline-rich region inhibits T-cell migration. Third College of Health Sciences Research Conference 2002.

2001

  • Young, J., Stewart, G., Fulcher, D., Benson, E., Ffrench, R., Clarkson, J., Liang,, T., Tideman, R., Packham, D. (2001). In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by Interleukin-12 (IL-12). AIDS Research and Human Retroviruses, 17, 233-242.
  • Gala, S., Stewart, G., Williamson, P., Marreiros, A. (2001). Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood, 97, 227-234.

2000

  • Huang, Q., Teutsch, S., Buhler, M., Bennetts, B., Heard, R., Manolios, N., Stewart, G. (2000). Evaluation of the Apo-1/Fas promoter Mva 1 polymorphism in multiple sclerosis. Multiple Sclerosis: clinical and laboratory research, 6(1), 14-18.
  • Wallman, L., Stewart, G., Chapman, J., O'Connell, P., Fulcher, D. (2000). Mycophenolate mofetil for treatment of refractory lupus nephritis: four pilot cases. Internal Medicine Journal, 30, 712-715.

To update your profile click here. For support on your academic profile contact .